A drug that works by blocking the RANKL protein, limiting the activity level of certain bone cells, called osteoclasts, which help cause the bone weakening and damage that can happen when breast cancer spreads to the bone. It belongs to a group of drugs called RANKL inhibitors.
Read more about Xgeva (chemical name: denosumab).
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
©2012 Breastcancer.org - All rights reserved.